To make things easier, leave this box checked On shared devices, we recommend that you disconnect from Euroquity when you are done
Email

You will receive an email to define a new password

Location

Select your country

and your language

Hi ,

Welcome to your personnel profile page! Fill in your information in order to become more visible to organizations that interest you.

% completed

%

medal 2
This profile is validated by 2 label.

Company

AMONETA DIAGNOSTICS

AMONETA DIAGNOSTICS_logo
34
EQ SCORE

The EQ Score shows the company's activity and appeal on the platform: profile completeness, news, likes, follows, membership in one or more labels or communities, number of members in its network, etc.

Amoneta Diagnostics offers a blood diagnostic test to detect and follow the Alzheimer’s Disease pathology, which shall also be used as an optimizing method for present and future treatments and drug development projects.

Huningue, Grand-Est, France

Send a message

English

AMONETA DIAGNOSTICS

English

Amoneta offers a unique diagnostic test for an unmet, high medical need: Reliable early diagnosis of Alzheimer's Disease.

The test is performed on a minimal blood sample, based on the detection of two complementary biomarkers. The first results show a reliability up to 95% in human subjects, even 100% in animals. The competitive advantages of ADDIA test are (1) the ease of implementation, rapid, minimally invasive, effective laboratory routine and inexpensive, (2)...

See more

Amoneta offers a unique diagnostic test for an unmet, high medical need: Reliable early diagnosis of Alzheimer's Disease.

The test is performed on a minimal blood sample, based on the detection of two complementary biomarkers. The first results show a reliability up to 95% in human subjects, even 100% in animals. The competitive advantages of ADDIA test are (1) the ease of implementation, rapid, minimally invasive, effective laboratory routine and inexpensive, (2) reliability, compared to all existing competitor tests (3) repeatability, the fact that it can be repeated without bias, unlike neuropsychological tests.

Compared to competitor companies developing blood biomarkers, Amoneta is ahead as it is the only company so far with clinical development on 1024 patients being recruited in its late stage clinical studies.

  • 1

    Like

Our latest news

Certifications

InvestHorizon - Accelerated
The InvestHorizon Accelerated label is for selected deep tech companies from the accelerator programme to facilitate series A funding.  This quality label is a guarantee for investors to find high standard project proposals from European SMEs with growth potential. InvestHorizon is a programme financed by the European Commission in association with Eureka to foster investment readiness.
454 Entities

Communities

InvestHorizon
InvestHorizon is an accelerator programme designed to facilitate the access to Series A funding for selected DEEP TECH companies.
2672 Members
France Angels
France Angels is a Nationale Federation of Business Angels. Nationale federation that federates, represents and promotes French Business Angels.
489 Members

Our history

Start in 2014

  • 2014

    Amoneta Diagnostics SAS is founded by Firalis SA and SODIV.

  • 2015

    ADDIA Project proposal has been awarded with a "Seal of Excellence" and a 5 Mio € grant by the EU.

  • 2016

    Amoneta obtained approvals from various ethic committee for its ADDIA multicentric clinical study.

  • Jan-2017

    Amoneta launched its ADDIA multicentric study aiming to do the proof-of-performance of its test.

  • Mar-2018

    Strasbourg Hospital finalized recruitments for the Chronobiological study (part of ADDIA Program).

to be continued ...